Cysteine analogs of recombinant barley ribosome inactivating protein form antibody conjugates with enhanced stability and potency in vitro.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Bioconjugate chemistry

• Publication date

  1994-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/BC00026A004PMID 8031875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2.

  1993cited by this paper
• Ricin A-chain cytotoxicity depends on its presentation to the cell membrane.

  1993cited by this paper
• Rational design of immunotoxins: current progress and future prospects.

  1992cited by this paper
• Efficacy of an anti-CD7-ricin A chain immunoconjugate in a novel murine model of human T-cell leukemia.

  1992cited by this paper
• Cytotoxic conjugates containing translational inhibitory proteins.

  1992cited by this paper
• Activity of recombinant mitogillin and mitogillin immunoconjugates.

  1992cited by this paper
• Therapeutic use of immunotoxins.

  1992cited by this paper
• Structure of ricin A‐chain at 2.5 Å

  1991cited by this paper
• Biochemical and molecular characterization of three barley seed proteins with antifungal properties.

  1991cited by this paper
• Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain.

  1991cited by this paper
• Rationale for clinical use of immunotoxins in cancer and autoimmune disease.

  1991cited by this paper
• Cytotoxicity against human peripheral blood mononuclear cells and T cell lines mediated by anti‐T cell immunotoxins in the absence of added potentiator

  1991cited by this paper
• Site-specific attachment to recombinant antibodies via introduced surface cysteine residues.

  1990cited by this paper
• Toxicity of, and histological lesions caused by, ribosome‐inactivating proteins, their IgG‐conjugates, and their homopolymers

  1990cited by this paper
• Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.

  1990cited by this paper
• Use of an anti-pan T-lymphocyte ricin a chain immunotoxin in steroid-resistant acute graft-versus-host disease.

  1990cited by this paper
• Substituted 2-iminothiolanes: reagents for the preparation of disulfide cross-linked conjugates with increased stability.

  1990cited by this paper
• An antimelanoma-barley ribosome inactivating protein conjugate is cytotoxic to melanoma cells in vitro.

  1990cited by this paper
• Immunotoxin construction with a ribosome-inactivating protein from barley.

  1990cited by this paper
• Antibody toxin conjugates: a perspective.

  1988cited by this paper
• The mechanism of action of barley toxin: a type 1 ribosome-inactivating protein with RNA N-glycosidase activity.

  1988cited by this paper
• Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin.

  1988cited by this paper
• Characterization of the Erwinia carotovora pelB gene and its product pectate lyase

  1987cited by this paper
• The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins.

  1987cited by this paper
• A simplified microassay for inhibition of protein synthesis in reticulocyte lysates by immunotoxins.

  1986cited by this paper
• The complete primary structure of protein synthesis inhibitor II from barley seeds

  1986cited by this paper
• High-level expression of M13 gene II protein from an inducible polycistronic messenger RNA.

  1985cited by this paper
• Isolation and characterization of inhibitors of animal cell-free protein synthesis from barley seeds

  1984cited by this paper
• Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.

  1984cited by this paper
• Inhibitors of animal cell-free protein synthesis from grains.

  1982cited by this paper

• BL22: A Milestone in Targeting CD22

  2017cites this paper
• Immunotoxins Constructed with Ribosome-Inactivating Proteins and their Enhancers: A Lethal Cocktail with Tumor Specific Efficacy

  2014influential citation
• Development of a platform technology for enhanced endo/lysosomal escape of targeted toxins by structurally specific oleanane saponins

  2014cites this paper
• Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs.

  2008cites this paper
• Immunotoxins for targeted cancer therapy

  2006cites this paper
• 4 – araB EXPRESSION SYSTEM IN Escherichia coli

  1999cites this paper
• Immunotoxins for targeted cancer therapy.

  1998cites this paper
• Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties.

  1998cites this paper